News & press releases

Page 1 of 64

  1. SMITH & NEPHEW AWARDED INNOVATIVE TECHNOLOGY DESIGNATION FOR ALLEVYN™ LIFE AT NOVATION INNOVATIVE TECHNOLOGY EXPO

    21st November 2014

    SMITH & NEPHEW AWARDED INNOVATIVE TECHNOLOGY DESIGNATION FOR ALLEVYN™ LIFE AT NOVATION INNOVATIVE TECHNOLOGY EXPO
  2. Smith & Nephew diversifies funding base with $800 million private placement

    20th November 2014

    Smith & Nephew diversifies funding base with $800 million private placement
  3. Smith & Nephew announces further optimisation of manufacturing footprint

    19th November 2014

    Smith & Nephew announces further optimisation of manufacturing footprint
  4. Appointment of Erik Engstrom as Non-Executive Director

    13th November 2014

    Appointment of Erik Engstrom as Non-Executive Director
  5. Appointment of Vinita Bali as Non-Executive Director

    30th October 2014

    Appointment of Vinita Bali as Non-Executive Director
  6. Smith & Nephew 2014 Q3 Results

    30th October 2014

    Smith & Nephew 2014 Q3 Results
  7. Smith & Nephew Advanced Wound Therapies REGRANEX◊ (BECAPLERMIN) GEL, 0.01%, OASIS® Wound Matrix and OASIS® Ultra Tri-Layer Matrix awarded APMA Seal of Approval

    27th October 2014

    Smith & Nephew Advanced Wound Therapies REGRANEX◊ (BECAPLERMIN) GEL, 0.01%, OASIS® Wound Matrix and OASIS® Ultra Tri-Layer Matrix awarded APMA Seal of Approval
  8. US Patent and Trademark Office confirms validity of Smith & Nephew patent

    27th October 2014

    US Patent and Trademark Office confirms validity of Smith & Nephew patent

Page 1 of 64